News

The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation ...
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
The U.K.’s National Institute for Health and Care Excellence (NICE) recommends the use of pulsed field ablation as an option ...
Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...
Boston Scientific (NYSE: BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib.
Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, ...
Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ...
The medtech startup founded by physician and Farapulse inventor Steven Mickelsen is preparing to begin a pivotal study of ...
Kardium Inc., the developer of the Globe ® Pulsed Field System - an innovative treatment for atrial fibrillation (AF) - has ...
Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...
Introduction: Currently, the treatment of atrial fibrillation (AF) focuses on restoring sinus rhythm with pulmonary vein isolation (PVI). Pulsed-field ablation (PFA) is a novel, promising method that ...
BC heart device maker Kardium has secured $340 million CAD in financing to fuel the launch of its innovative atrial ...